UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000007413
Receipt No. R000008734
Scientific Title Phase II Study of Safety and Efficacy. Dasatinib in Patients with Chronic Phase Chronic Myelogenous Leukemia achieving a Major Molecular Response on Imatinib.
Date of disclosure of the study information 2012/03/01
Last modified on 2016/12/14 16:07:32

No. Disposal Last modified on Item of update
1 Insert 2012/03/01 10:00:28
2 Update 2012/03/01 10:14:40 Key exclusion criteria
3 Update 2012/03/02 15:27:20 Institutions
4 Update 2012/05/29 11:44:02 Recruitment status
5 Update 2012/10/01 09:35:15 Email
Email1
Institutions
6 Update 2012/10/17 14:14:10 Email
Email1
7 Update 2013/03/01 09:19:54 Institutions
8 Update 2013/09/01 09:08:25 Email
Email
Institutions
9 Update 2015/03/30 17:19:23 Recruitment status
10 Update 2016/12/14 16:06:44 Key inclusion criteria
11 Update 2016/12/14 16:07:32 Name of primary sponsor
Organization


Contact us.